- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2016
- Public Summary Document (PSD) November 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2016 PBAC Meeting - Word
Icatibant – November 2016
Icatibant: Injection 30 mg (as acetate) in 3 mL single use pre-filled syringe; Firazyr®
Last updated
17 March 2017